Table 5 Diagnostic accuracy of individual pleural fluid tests for distinguishing CPPE as compared with UPPE.

From: Proteome profiling reveals novel biomarkers to identify complicated parapneumonic effusions

Biomarker Candidates

Cutoff

Sensitivity (%)

Specificity (%)

PPV (%)

NPV (%)

OR (95% confidence interval)

AUC (95% confidence interval)

BPI

> 10 ng/ml

97.0

91.4

91.4

97.0

341.3 (33.7, 3458.1)

0.966 (0.925–1.000)

NGAL

> 600 ng/ml

75.8

94.3

92.6

80.5

51.6 (10.1, 264.3)

0.875 (0.788–0.963)

AZU1

> 175 ng/ml

97.0

65.7

72.7

95.8

61.3 (7.4, 505.5)

0.807 (0.700–0.914)

Calprotectin

> 90 μg/ml

81.8

94.3

93.1

84.6

74.3 (13.9, 398.1)

0.937 (0.879–0.995)

LDH

> 1000 U/l

81.8

100

100

85.4

144 (48.0, 431.9)

0.915 (0.836–0.994)

Glucose

< 60 mg/dl

75.8

100

100

81.4

104 (35.1, 307.8)

0.907 (0.829–0.985)

pH

< 7.2

75.8

100

100

81.4

104 (35.1, 307.8)

0.947 (0.898–0.996)

  1. PPV: positive predictive values; NPV: negative predictive values; AUC: area under ROC curve; BPI: bactericidal permeability-increasing protein; NGAL: neutrophil gelatinase-associated lipocalin; AZU1: azurocidin. The parapneumonic effusion (PPE, refer to UPPE and CPPE) and non-parapneumonic effusion (non-PPE, refer to transudates, other exudates, and malignant) in this study.